These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6104782)

  • 1. Iodohydroxybenzylpindolol: preparation, purification, localization of its iodine to the indole ring, and characterization as a partial agonist.
    Bearer CF; Knapp RD; Kaumann AJ; Swartz TL; Birnbaumer L
    Mol Pharmacol; 1980 May; 17(3):328-38. PubMed ID: 6104782
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta adrenoceptor interaction of full and partial agonists in the cat heart and soleus muscle.
    Hedberg A; Mattsson H
    J Pharmacol Exp Ther; 1981 Dec; 219(3):798-808. PubMed ID: 6117657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid high yield synthesis of no-carrier-added (-)-[123I]iodocyanopindolol.
    Van Dort ME; Gildersleeve DL; Wieland DM
    Int J Rad Appl Instrum A; 1991; 42(3):309-11. PubMed ID: 1676024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenoceptor blocking agents and their effects on heart and blood vessels.
    Clark BJ
    Arq Bras Cardiol; 1984 Apr; 42(4):237-42. PubMed ID: 6150700
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and HPLC assessment of N-nitrosoderivatives from six beta-adrenergic antagonists.
    Mazzei M; Sottofattori E; Balbi A; Robbiano L
    Farmaco; 1991 Sep; 46(9):1043-9. PubMed ID: 1687242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of new delta 2-isoxazoline derivatives and their pharmacological characterization as beta-adrenergic receptor antagonists.
    Conti P; Dallanoce C; De Amici M; De Micheli C; Klotz KN
    Bioorg Med Chem; 1998 Apr; 6(4):401-8. PubMed ID: 9597184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis of new amino-halogen substituted phenyl-amino ethanols].
    Keck J; Krüger G; Noll K; Machleidt H
    Arzneimittelforschung; 1972 May; 22(5):861-9. PubMed ID: 4403125
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions of agonists and antagonists with beta-adrenergic receptors.
    Molinoff PB; Weiland GA; Heidenreich KA; Pittman RN; Minneman KP
    Adv Cyclic Nucleotide Res; 1981; 14():51-67. PubMed ID: 6116391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells.
    Pittman RN; Molinoff PB
    Mol Pharmacol; 1983 Nov; 24(3):398-408. PubMed ID: 6138704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation.
    Gando S; Hattori Y; Akaishi Y; Nishihira J; Kanno M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):475-84. PubMed ID: 9223590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac beta receptors--experimental aspects].
    Kaumann AJ
    Z Kardiol; 1983 Feb; 72(2):63-82. PubMed ID: 6133398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UPLC/MS for the identification of beta-blockers.
    Wren SA; Tchelitcheff P
    J Pharm Biomed Anal; 2006 Feb; 40(3):571-80. PubMed ID: 16413161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin reduces beta-adrenergic contractile response in rabbit hearts. Ca(2+)-dependent inhibition of adenylyl cyclase activity via Na+/Ca2+ exchange.
    Nagai K; Murakami T; Iwase T; Tomita T; Sasayama S
    J Clin Invest; 1996 Jan; 97(1):6-13. PubMed ID: 8550851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample preparation on polymeric solid phase extraction sorbents for liquid chromatographic-tandem mass spectrometric analysis of human whole blood--a study on a number of beta-agonists and beta-antagonists.
    Josefsson M; Sabanovic A
    J Chromatogr A; 2006 Jul; 1120(1-2):1-12. PubMed ID: 16600255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanine nucleotides modulate the affinity of antagonists at beta-adrenergic receptors.
    Wolfe BB; Harden TK
    J Cyclic Nucleotide Res; 1981; 7(5):303-12. PubMed ID: 6124564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors.
    Weiland GA; Minneman KP; Molinoff PB
    Mol Pharmacol; 1980 Nov; 18(3):341-7. PubMed ID: 6110167
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-Adrenergic receptor interactions. Characterization of iodohydroxybenzylpindolol as a specific ligand.
    Brown EM; Aurbach GD
    J Biol Chem; 1976 Mar; 251(5):1232-8. PubMed ID: 1254565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human heart beta-adrenergic receptors. I. Heterogeneity of the binding sites: presence of 50% beta 1- and 50% beta 2-adrenergic receptors.
    Robberecht P; Delhaye M; Taton G; De Neef P; Waelbroeck M; De Smet JM; Leclerc JL; Chatelain P; Christophe J
    Mol Pharmacol; 1983 Sep; 24(2):169-73. PubMed ID: 6136900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of certain 3-[4-[2-hydroxy-3-(isopropylamino) propoxy]phenyl]propionate as beta-adrenergic blocking agents.
    Ahmed AN
    J Pharm Belg; 1987; 42(6):389-94. PubMed ID: 2895806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.